- Filed
- Mar 12, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Mar 6, 2025 | 7.19M sh |
| Rd Expense | FY 2024 · Dec 31, 2024 | $2.36M |
| Rd Expense | FY 2024 · Dec 31, 2023 | $5.32M |
| Shares Diluted restated | FY 2024 · Dec 31, 2023 | 5.52M sh |
| Capex | FY 2024 · Dec 31, 2023 | $206K |
| Operating Cash Flow | FY 2024 · Dec 31, 2023 | −$14.67M |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $10.33M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $8.12M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $8.66M |
| Current Assets | FY 2024 · Dec 31, 2023 | $14.29M |
| Total Assets | FY 2024 · Dec 31, 2023 | $16.1M |
| Eps Diluted | FY 2024 · Dec 31, 2023 | −$3.42 |
| Eps Basic | FY 2024 · Dec 31, 2023 | −$3.42 |
| Sga Expense | FY 2024 · Dec 31, 2023 | $27.17M |
| Net Income | FY 2024 · Dec 31, 2023 | −$18.83M |
| Operating Income | FY 2024 · Dec 31, 2023 | −$19.27M |
| Gross Profit | FY 2024 · Dec 31, 2023 | $13.23M |
| Cost Of Revenue | FY 2024 · Dec 31, 2023 | $2.8M |
| Revenue | FY 2024 · Dec 31, 2023 | $16.03M |
| Stockholders Equity | FY 2024 · Dec 31, 2022 | $17.09M |